Investment for health and wellbeing
Reports and presentationsOriola operates in the Finnish and Swedish health and wellbeing markets
Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.
New state-of-the-art distribution centre in Finland
Oriola accelerates growth and modernises Finnish operations with a highly automated, state-of-the-art distribution centre in Järvenpää. Construction of this facility is scheduled to commence in the first quarter of 2026, with the relocation of operations from Espoo to Järvenpää anticipated to start by the end of 2027.
Interim Report Q3 2025
Sales margin growth and improved adjusted EBITDA
Oriola's science-based climate targets
Oriola’s ambitious science-based climate targets approved by the SBTi. This approval makes Oriola one of the companies globally recognised by the SBTi as having an approved science-based net-zero target under the SBTi Net-Zero Standard.
Latest stock exchange releases
Latest investor news
